The amount of private, capital-backed healthcare deals has significantly declined.
There has been a higher level of capital invested in 2022 so far, mainly because of Bain Capital and Hellman & Friedman’s $17 billion buyout of health tech company Athenahealth in the first quarter. Read more.

Healthcare Dealmaking Will Heat Up in 2023 with Plenty of Corporate Cash, PE ‘Dry Powder’

Increasing transaction volumes and players embracing value-based care—coupled with large levels of corporate cash and private equity "dry powder"—are leading to continued expansion for deal volumes in 2023, according to a new analysis from PwC.

December 9, 2022

Exclusive: AI Integration in Healthcare Takes Off

Healthcare providers and investors alike will be wise to approach AI implementation with caution, addressing the risks and liabilities healthcare professionals may face amid threats to data privacy, algorithmic bias, and lack of human oversight.

June 26, 2023

As Politics Infects Public Health, Private Companies Profit

For some counties and cities that share a public health agency with other local governments, differences over mask mandates, business restrictions, and other covid preventive measures have strained those partnerships.

February 17, 2022

How Walmart Became a Major Player in the Healthcare Industry

Walmart Health started in 2019 with the goal of providing affordable healthcare services to its communities. The company has since launched over 25 centers across Georgia, Arkansas, Illinois, and Florida.

March 16, 2023

PE Deal-Making in Healthcare: 5 Takeaways From 1st Half of 2022

Related Posts